NCT05261321View on ClinicalTrials.gov

Cannabis and Polysubstance Use: Response Inhibition and Stress Exposure

PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 15, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Healthy
Interventions
DRUG

Cannabis oil with a high ratio of THC to CBD

In the first active condition, cannabis oil with a high THC to CBD ratio will be administered to participants.

DRUG

Cannabis oil with a high ratio of CBD to THC

In the second active condition, cannabis oil with a high CBD to THC ratio will be administered to participants.

DRUG

Placebo

In the control condition, the placebo will be administered to participants.

Trial Locations (1)

V6T 1Z3

RECRUITING

B.R.A.I.N. Lab, Institute of Mental Health, Faculty of Medicine, University of British Columbia, Vancouver

All Listed Sponsors
lead

University of British Columbia

OTHER